Cargando…

Chloride imbalance in Fragile X syndrome

Developmental changes in ionic balance are associated with crucial hallmarks in neural circuit formation, including changes in excitation and inhibition, neurogenesis, and synaptogenesis. Neuronal excitability is largely mediated by ionic concentrations inside and outside of the cell, and chloride (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miles, Kaleb Dee, Doll, Caleb Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596984/ https://www.ncbi.nlm.nih.gov/pubmed/36312023 http://dx.doi.org/10.3389/fnins.2022.1008393

Ejemplares similares

Fmrp regulates neuronal balance in embryonic motor circuit formation
por: Barker, Chase M., et al.
Publicado: (2022)

Auditory Processing in Fragile X Syndrome
por: Rotschafer, Sarah E., et al.
Publicado: (2014)

Modeling Fragile X Syndrome in Drosophila
por: Drozd, Małgorzata, et al.
Publicado: (2018)

Of Men and Mice: Modeling the Fragile X Syndrome
por: Dahlhaus, Regina
Publicado: (2018)

Hyperexcitability and Homeostasis in Fragile X Syndrome
por: Liu, Xiaopeng, et al.
Publicado: (2022)

Event-related potential alterations in fragile X syndrome
por: Knoth, Inga S., et al.
Publicado: (2012)

Fragile X Syndrome: Prevalence, Treatment, and Prevention in China
por: Niu, Manman, et al.
Publicado: (2017)

Deficient Sleep in Mouse Models of Fragile X Syndrome
por: Saré, R. Michelle, et al.
Publicado: (2017)

Neurodevelopment and early pharmacological interventions in Fragile X Syndrome
por: Milla, Luis A., et al.
Publicado: (2023)

Dynamic Object Representations in Infants with and without Fragile X Syndrome
por: Farzin, Faraz, et al.
Publicado: (2010)

The contribution of inhibitory interneurons to circuit dysfunction in Fragile X Syndrome
por: Cea-Del Rio, Christian A., et al.
Publicado: (2014)

Reevaluation of FMR1 Hypermethylation Timing in Fragile X Syndrome
por: Mor-Shaked, Hagar, et al.
Publicado: (2018)

Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance
por: Ethridge, Lauren E., et al.
Publicado: (2019)

From circuits to behavior: Amygdala dysfunction in fragile X syndrome
por: Svalina, Matthew N., et al.
Publicado: (2023)

Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions
por: Bach, Snow, et al.
Publicado: (2021)

MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID, and Fragile X syndrome
por: Siew, Wei-Hong, et al.
Publicado: (2013)

STDP and Mental Retardation: Dysregulation of Dendritic Excitability in Fragile X Syndrome
por: Meredith, Rhiannon M., et al.
Publicado: (2010)

The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?
por: Castagnola, Sara, et al.
Publicado: (2017)

Structural and Functional Abnormalities in the Olfactory System of Fragile X Syndrome Models
por: Bodaleo, Felipe, et al.
Publicado: (2019)

Peripheral Amyloid Precursor Protein Derivative Expression in Fragile X Syndrome
por: McLane, Richard D., et al.
Publicado: (2019)

Altered Gut Microbiota in a Fragile X Syndrome Mouse Model
por: Altimiras, Francisco, et al.
Publicado: (2021)

Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments
por: Tempio, Alessandra, et al.
Publicado: (2023)

Editorial: Recent advances in mechanisms and therapeutics for Fragile X Syndrome and autism
por: Molinaro, Gemma, et al.
Publicado: (2023)

Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome
por: Uutela, Marko, et al.
Publicado: (2014)

Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes
por: Wang, Hansen, et al.
Publicado: (2015)

Stress Odorant Sensory Response Dysfunction in Drosophila Fragile X Syndrome Mutants
por: Androschuk, Alaura, et al.
Publicado: (2018)

Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders
por: Telias, Michael
Publicado: (2019)

Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome
por: Cogram, Patricia, et al.
Publicado: (2019)

Myelination Deficits in the Auditory Brainstem of a Mouse Model of Fragile X Syndrome
por: Lucas, Alexandra, et al.
Publicado: (2021)

Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017)

Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain
por: Aby, Franck, et al.
Publicado: (2022)

APP Causes Hyperexcitability in Fragile X Mice
por: Westmark, Cara J., et al.
Publicado: (2016)

Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome
por: Mines, Marjelo A., et al.
Publicado: (2011)

CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome
por: Abekhoukh, Sabiha, et al.
Publicado: (2014)

Targeted Reactivation of FMR1 Transcription in Fragile X Syndrome Embryonic Stem Cells
por: Haenfler, Jill M., et al.
Publicado: (2018)

Neuroactive Steroids Reverse Tonic Inhibitory Deficits in Fragile X Syndrome Mouse Model
por: Modgil, Amit, et al.
Publicado: (2019)

Fragile X-Associated Tremor/Ataxia Syndrome: From Molecular Pathogenesis to Development of Therapeutics
por: Kong, Ha Eun, et al.
Publicado: (2017)

Fragile X Syndrome
por: McLennan, Yingratana, et al.
Publicado: (2011)

Fragile X Syndrome
por: Saldarriaga, Wilmar, et al.
Publicado: (2014)

Hyperexcitability of Sensory Neurons in Fragile X Mouse Model
por: Deng, Pan-Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ni1h5b3h6qbfpdcg3d0slft6q7